Sponsors & CROs
Review investigator experience, clinical fit and study-specific qualification requirements.
Submit a studyRenuviaMD Research · Florida
Principal Investigator and Sub-Investigator support for research sites, sponsors and CROs in South and Central Florida.
Combining investigator experience with medical directorship at research sites.

Florida LicenseME 84789
National Provider Identifier1447295126
Good Clinical PracticeDrugs & devices
BilingualEnglish / Spanish
Work with RenuviaMD
Review investigator experience, clinical fit and study-specific qualification requirements.
Submit a studyDefine how investigator duties integrate with your personnel, systems and operations.
Discuss a partnershipExpress interest in PI or Sub-I roles matched to your credentials, experience and availability.
Join the investigator teamResearch medical leadership
Medical leadership in Homestead, Florida, with study-specific investigator responsibilities. Investigator appointments and duties are defined for each protocol.
Medical leadership for an in-office research model. NexGen’s research team coordinates operations and works with each practice’s physician investigator.
Selected research experience
| Role | Study / area | Phase / type | Dates | Status / scope |
|---|---|---|---|---|
| Principal Investigator | Metabolic / endocrine | I | 2026–Present | Assignment; signed FDA 1572 submitted |
| Principal Investigator | Clinical Benchmarking Study of the LIAISON NES® CT/NG/TV Assay · DSM-PROT-005314 | Investigational diagnostic device study | Current | Ongoing at Sina Medical Center |
| Principal Investigator | COPD / chronic bronchitis · PILLAR | III | 2021–2023 | Through site closeout, March 2023 |
The collaboration model
RenuviaMD provides investigator services and site research medical leadership, with responsibilities agreed for each site and protocol.
Medical protocol review, clinical eligibility, safety oversight, medical decisions, documented delegation, and investigator coverage.
Physician leadership for site feasibility and study preparation, staff qualifications and training oversight, and clinical discussions with sponsors and CROs. Responsibilities are defined for each site and study.
Facilities, personnel, responsibilities, coverage, and sponsor/CRO requirements are confirmed before an investigator appointment is accepted.
Investigator qualification
Onboarding includes credentials and training review, availability, scope of practice, and study-specific duties. PI/Sub-I appointments are determined per protocol; team composition does not imply sponsor approval.
The site’s operational team manages study coordination and daily execution; the PI retains oversight of delegated study activities.
Optional consulting
A separate service to organize capability evidence and prioritize improvements. Scope, deliverables and timing are agreed for each assessment.
Review the scope